Market Size in 2020 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 401.32 Billion | USD 832.11 Billion | 11.32% | 2020 |
The global Pharmaceutical Manufacturing market size accrued earnings worth approximately 401.32 ( USD Billion) in 2020 and is predicted to gain revenue of about 832.11 ( USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028.
The report offers an assessment and analysis of the Pharmaceutical Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Pharmaceutical manufacturing is the method of industrial-scale synthesizing of pharma drugs and it is also a part & parcel of the pharma sector. The procedure of drug production also termed pharmaceutical manufacturing is divided into a number of unit functions including milling, coating, granulation, and tablet pressing. Furthermore, the pharma sector has undergone a humongous change with the evolution of novel & cost-efficient techniques along with the introduction of new approaches in the pharma manufacturing industry. The surge in the funding of pharma manufacturing processes in the pharmaceutical industry will translate into the enlarged scope of the pharmaceutical manufacturing industry in the upcoming years. Apart from this, pharma production downtime & output of product wastage are minimized with the execution of AI & robotic systems.
Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in the domain of personalized medicine has led to the exploration & development of patient-centric models, thereby further creating new growth avenues for the pharmaceutical manufacturing business. Apparently, altering the landscape of small drugs in drug potency terms, medicine complexity, business makeup, and production trends is predicted to aid demand for small drugs in the pharma sector. This, in turn, will prompt the expansion of the pharmaceutical manufacturing industry over the forecast period.
Moreover, an increase in medicine approvals by regulatory authorities such as the U.S. FDA is projected to boost drug manufacturing procedures, thereby completely transforming the phase of growth of the pharmaceutical manufacturing industry. Additionally, a massive rise in funding of clinical experiments by pharma firms & surge in research activities on new drug development will steer the growth of the pharmaceutical manufacturing market.
Report Attributes | Report Details |
---|---|
Report Name | Pharmaceutical Manufacturing Market Research Report |
Market Size in 2020 | USD 401.32 Billion |
Market Forecast in 2028 | USD 832.11 Billion |
Growth Rate | CAGR of 11.32% |
Number of Pages | 255 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc., and Bristol Myers Squibb Company. |
Segments Covered | By Drug Type, By Drug Development, By Formulation, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Base Year | 2020 |
Historical Year | 2018 to 2020 |
Forecast Year | 2021 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America To Contribute Majorly Towards Global Market Size By 2028
The expansion of the pharmaceutical manufacturing industry in North America during 2021-2028 is due to a huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, a rise in spending on prescribed medicines in the U.S. will spur regional market size within the next couple of years. Apart from this, an increase in the number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in the ensuing years.
Key players profiled in the report and leveraging the industry landscape are
FrequentlyAsked Questions
Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in domain of personalized medicine has led to exploration & development of patient-centric models, thereby further creating new growth avenues for pharmaceutical manufacturing business.
According to Zion market research report, the global Pharmaceutical Manufacturing market Size accrued earnings worth approximately 401.32(USD Billion) in 2020 and is predicted to gain revenue of about 832.11 (USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is subject to huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, rise in spending on prescribed medicines in the U.S. will spur regional market size within next couple of years. Apart from this, increase in number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in ensuing years.
The key market participants include Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc., and Bristol Myers Squibb Company.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed